42 completed, 5 recruiting, 5 terminated, 4 unknown. 60 Phase 2, 12 Phase 1, 12 Phase 3.
Follow Water: new trials by email Literature Review of Water trials Research Report on Water
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid Rehydration for Severe Hypernatremia Intravenous Dextrose 5% solution - Hypernatremia | Phase 2 | Recruiting | Columbia University | 80 | 2026-10-22 | 2026-10-27 |
| Racecadotril for Organ Injury in Sepsis Patients Racecadotril, Water (Placebo) - Sepsis | Phase 1 / Phase 2 | Enrolling by invitation | Zhujiang Hospital | 44 | 2026-05-06 | 2026-05-28 |
| Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases 1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water, 1.0% IP-001 for Injection, a 1 mg/mL solution of IP-001 in water., Microwave (thermal) tumor ablation - Colorectal Cancer (CRC), Colon Cancer Liver Metastases | Phase 2 / Phase 3 | Not yet recruiting | Immunophotonics, Inc. | 717 | 2026-05-01 | 2026-01-07 |
| Postpartum 8-aminoquinoline Breast Milk Study Daily primaquine (0.5 mg/kg per day) for 14 days given with food food and water, Daily primaquine 1 mg/kg per day for 7 days given with food and water, Single-dose tafenoquine given with food and water to prevent gastrointestinal discomfort - Drug Pharmacokinetics in Healthy Volunteers | Phase 2 / Phase 3 | Not yet recruiting | Curtin University | 60 | 2026-04-01 | 2026-03-18 |
| Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19) PepGNP-COVID19 (One vaccination), Water for injection (One vaccination), PepGNP-COVID19 (Two vaccinations) - Coronavirus, SARS-CoV-2 Infection | Phase 1 / Phase 2 | Not yet recruiting | Gylden Pharma Ltd | 110 | 2025-09-01 | 2025-02-24 |
| Efficacy Testing of a Multi-Level Family Planning Intervention Family Planning Intervention, Water, Sanitation, and Hygiene (WASH) Intervention - Unintended Pregnancy, Family Planning | Phase 2 / Phase 3 | Recruiting | Boston College | 1464 | 2025-06-12 | 2026-03-23 |
| The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi Gum Arabic, Water - End Stage Renal Disease (ESRD) | Phase 1 / Phase 2 | Recruiting | Abu Dhabi Health Services Company | 40 | 2025-02-03 | 2025-02-20 |
| Epsom Salt Compresses to Relieve Perineal for Postpartum Care: a Clinical Trial Epsom salt, Water - Perineal Injury, Pain | Phase 2 | Recruiting | Antoine Roger | 90 | 2024-06-15 | 2024-12-19 |
| Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke Acetylcysteine, Dextrose in Water - Acute Ischemic Stroke | Phase 2 | Completed | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 4 | 2023-11-02 | 2026-02-19 |
| Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number. Sodium Chloride Granules, Water - Melanoma (Skin) | Phase 2 | Unknown | Rafik Batroussy | 20 | 2023-08-01 | 2023-05-11 |
| Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial. Colostrum Nasal Spray, Water for injection - COVID 19 | Phase 1 / Phase 2 | Completed | Hadassah Medical Organization | 43 | 2023-05-01 | 2025-03-04 |
| Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO) NFL-101, Placebo - Smoking Cessation, Nicotine Dependence | Phase 2 | Completed | NFL Biosciences SAS | 34 | 2023-02-21 | 2023-10-19 |
| Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease Sargramostim, Saline - placebo comparator - Alzheimer Disease | Phase 2 | Recruiting | University of Colorado, Denver | 42 | 2022-06-01 | 2026-04-30 |
| Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4) Trilaciclib, Placebo, Docetaxel - Metastatic Non-Small Cell Lung Cancer, NSCLC | Phase 2 | Terminated | G1 Therapeutics, Inc. | 10 | 2021-04-30 | 2023-04-14 |
| Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) Oral-B Mouth Sore mouthwash, Crest Pro-Health Multi-Protection mouthwash, CloSYS Ultra Sensitive Rinse mouthwash - COVID-19, SARS-CoV 2 | Phase 2 | Terminated | University of California, San Francisco | 54 | 2021-03-31 | 2023-11-18 |
| Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19 Water, Peroxyl, Periogard - COVID19, Coronavirus Infection | Phase 2 | Terminated | University of North Carolina, Chapel Hill | 2 | 2021-03-26 | 2022-02-16 |
| Tolerability and Efficacy of RJX in Patients With COVID-19 Rejuveinix (RJX) Active Comparator, Placebo Comparator - COVID-19, Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Unknown | Reven Pharmaceuticals, Inc. | 237 | 2021-03-25 | 2022-03-15 |
| A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis AMY-101, Water for injection - Gingivitis | Phase 1 / Phase 2 | Completed | Amyndas Pharmaceuticals S.A. | 39 | 2019-07-22 | 2021-02-21 |
| Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis Vitamin C, Dextrose 5% in water - Alcoholic Hepatitis, Sepsis | Phase 2 | Completed | Virginia Commonwealth University | 20 | 2019-04-16 | 2023-08-28 |
| Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Postoperative Pain Following Total Hip Arthroplasty. VVZ-149 injections, Placebo - Post-Operative Pain | Phase 2 | Completed | Vivozon, Inc. | 12 | 2017-12-20 | 2019-03-13 |
Showing 20 of 60. Sign in to see all of them.
COVID-19 (5) · Coronavirus Infections (3) · Diabetes Mellitus (3) · Pain (3) · Pain, Postoperative (3) · Sepsis (3) · Alzheimer Disease (2) · Autistic Disorder (2) · Dental Caries (2) · Infections (2) · Insulin Resistance (2) · Mucositis (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Obesity (2)
Vivozon, Inc. (3) · Hadassah Medical Organization (2) · Neuren Pharmaceuticals Limited (2) · The University of Hong Kong (2) · Tranzyme, Inc. (2) · Trevena Inc. (2) · University of Colorado, Denver (2) · University of Toronto (2) · Virginia Commonwealth University (2) · Abu Dhabi Health Services Company (1) · Amyndas Pharmaceuticals S.A. (1) · Antoine Roger (1) · Boston College (1) · Bristol-Myers Squibb (1) · British Columbia Cancer Agency (1)
United States (26) · Canada (7) · China (3) · South Korea (3) · India (2) · Israel (2) · Norway (2) · Taiwan (2) · United Kingdom (2) · Australia (1) · Denmark (1) · France (1) · Greece (1) · Italy (1) · Kenya (1)
Seonjun Bae, MD, PhD (3) · Edward CM Lo, BDS, PhD (2) · G. Harvey Anderson, Ph.D. (2) · Huntington Potter, PhD (2) · Alan Percy, MD (1) · Alberto R Edison, MD (1) · Alexander Kolevzon, MD (1) · Alexander Kulik, MD (1) · Alpha B. Fowler, MD (1) · Antoine Roger (1) · Arthur Beisang, MD (1) · Arun J Sanyal, MD (1) · Brioni Moore, PhD (1) · Bryan King, MD (1)
PMID 15269196, PMID 16219100, PMID 17999333, PMID 18973181, PMID 19479191, PMID 20042524, PMID 20878941, PMID 21135365, PMID 21958773, PMID 22297835, PMID 23241359, PMID 24022265, PMID 24030409, PMID 24768671, PMID 25168404, PMID 25200049, PMID 25664323, PMID 26338107, PMID 26579854, PMID 28589039, PMID 28734623, PMID 29859084, PMID 30611255, PMID 30938645, PMID 31573637, PMID 32328307, PMID 32539079, PMID 32660869, PMID 33435475, PMID 33778150, PMID 33896052, PMID 33900493, PMID 34483038, PMID 34618684, PMID 35208961, PMID 35224732, PMID 35230699, PMID 35603590, PMID 36066991, PMID 36092515, PMID 36671523, PMID 3692386, PMID 37460385, PMID 38363467, PMID 40337980, PMID 42238425, PMID 6683227
1UM1HL116885-01 (1), 2015 (1), 2025 (1), P01DK068055 (1), R01AG071151 (1), R01DK149765 (1), R01HD113806 (1), R21CA158530 (1), U01AA026966 (1)